A 55-year-old with recurrent gout (≥3 flares/year), SU 9.2 mg/dL, and CKD stage 3 is not on urate-lowering therapy. Which strategy aligns with guidelines?AFebuxostat at high fixed dose without titrationBProbenecid as first-line in CKD stage 3CStart allopurinol at low dose (≤100 mg/day; lower in CKD) with titration to SU <6 mg/dL and anti-inflammatory prophylaxisDDelay ULT until flares stop for 12 monthsETreat flares only; no ULT neededCheck my answer